€988,404
▲ Purchases (13 ops.)
Explore the detailed record of transactions filed by Funicular Fund, LP. Director active across 1 company, notably ARCA biopharma, Inc.. Aggregated, 13 disclosures have been recorded. Breakdown: 13 buys · 0 sell. Total volume traded: €988k. History available since 4 April 2022. The latest transaction was disclosed on 23 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations 13 total
2,301 shares @ US$2.295 0.5% of flow Common Stock SEC:0000921895-22-001792:0
Ideal exit: 17 Feb 2023 (T+270) 13,072 shares @ US$2.3046 2.9% of flow Common Stock SEC:0000921895-22-001755:0
Ideal exit: 12 Feb 2023 (T+270) 27,922 shares @ US$2.2698 6.2% of flow Common Stock SEC:0000921895-22-001688:0
Ideal exit: 6 Feb 2023 (T+270) 20,979 shares @ US$2.2845 4.6% of flow Common Stock SEC:0000921895-22-001599:0
Ideal exit: 4 Feb 2023 (T+270) 16,903 shares @ US$2.2747 3.7% of flow Common Stock SEC:0000921895-22-001519:0
Ideal exit: 30 Jan 2023 (T+270) 23,381 shares @ US$2.3169 5.2% of flow Common Stock SEC:0000921895-22-001438:0
Ideal exit: 23 Jan 2023 (T+270) 13,751 shares @ US$2.2913 3.0% of flow Common Stock SEC:0000921895-22-001390:0
Ideal exit: 20 Jan 2023 (T+270) 9,119 shares @ US$2.3117 2.0% of flow Common Stock SEC:0000921895-22-001318:0
Ideal exit: 13 Jan 2023 (T+270) 17,410 shares @ US$2.3289 3.8% of flow Common Stock SEC:0000921895-22-001257:0
Ideal exit: 9 Jan 2023 (T+270) 30,660 shares @ US$2.3109 6.6% of flow Common Stock SEC:0000921895-22-001225:0
Ideal exit: 3 Jan 2023 (T+270) 122,342 shares @ US$2.2585 25.5% of flow Common Stock SEC:0000921895-22-001177:0
Ideal exit: 30 Dec 2022 (T+270) 49,728 shares @ US$2.3019 10.6% of flow Common Stock SEC:0000921895-22-001178:0
Ideal exit: 31 Dec 2022 (T+270) 122,342 shares @ US$2.2585 25.5% of flow Common Stock SEC:0000921895-22-001091:0
Ideal exit: 30 Dec 2022 (T+270) About Funicular Fund, LP Funicular Fund, LP is a director and insider at ARCA biopharma, Inc.